JUN and melanoma: One such approach involves the use of the antiarrhythmic drug propafenone, which sensitizes melanoma cells to necroptosis by activating the JNK/JUN signaling pathway, upregulating mitochondrial heme oxygenase 1 (HMOX1), and inducing iron overload and ROS accumulation.